Author Index
Search or browse for an author across our entire electronic archive
Search results for: M
Results 41 - 50 of 2592 shown below
Möslinger, R
T M U Wagner, R Möslinger, G Langbauer, R Ahner, E Fleischmann, A Auterith, A Friedmann, T Helbich, C Zielinski, E Pittermann, M Seifert and P Oefner
Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations
doi:10.1054/bjoc.1999.1086
Mössner, E
S Q Ashraf, P Umana, E Mössner, T Ntouroupi, P Brünker, C Schmidt, J L Wilding, N J Mortensen and W F Bodmer
Humanised IgG1 antibody variants targeting membrane-bound carcinoembryonic antigen by antibody-dependent cellular cytotoxicity and phagocytosis
doi:10.1038/sj.bjc.6605355
Abstract | Full article | PDF
Mössner, J
J Rohloff, J Zinke, K Schoppmeyer, A Tannapfel, H Witzigmann, J Mössner, C Wittekind and K Caca
Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma
doi:10.1038/sj.bjc.6600232
Abstract | Full article | PDF
-
J Rohloff, J Zinke, K Schoppmeyer, A Tannapfel, H Witzigmann, J Mössner, C Wittekind and K Caca
Heparanase is a prognostic indicator for postoperative survival in pancreatic carcinoma
doi:10.1038/sj.bjc.6600504
Abstract | Full article | PDF
-
M Hermes, W Schormann, M Brulport, K Uhlemann, F Lupatsch, L C Horn, A Schumann, C Allgaier, M Weishaupt, K Engeland, G A Müller, J Mössner, A Bauer, I B Schiffer, S Gebhard, M Schmidt, E Lausch, D Prawitt, C Wilhelm and J G Hengstler
Trastuzumab therapy vs tetracycline controlled ERBB2 downregulation: influence on tumour development in an ERBB2-dependent mouse tumour model
advance online publication, 2008-04-29 00:00:00.000;
doi:10.1038/sj.bjc.6604318
Abstract | Full article | PDF
-
A Tannapfel, K Engeland, L Weinans, A Katalinic, J Hauss, J Mössner and Ch Wittekind
Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver
doi:10.1038/sj.bjc.6690465
-
U Halm, T Schumann, I Schiefke, H Witzigmann, J Mössner and V Keim
Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer
doi:10.1054/bjoc.1999.1035
Müerköster, S
S Müerköster, M A Weigand, C Choi, H Walczak, V Schirrmacher and V Umansky
Superantigen reactive V
6+ T cells induce perforin/granzyme B mediated caspase-independent apoptosis in tumour cellsdoi:10.1038/sj.bjc.6600104
Abstract | Full article | PDF
Mühl, B
C S Djuzenova, B Mühl, M Fehn, U Oppitz, B Müller and M Flentje
Radiosensitivity in breast cancer assessed by the Comet and micronucleus assays
advance online publication, 2006-03-14 00:00:00.000;
doi:10.1038/sj.bjc.6603005
Abstract | Full article | PDF
Mühlbauer, K-R
K-R Mühlbauer, H-J Gröne, T Ernst, E Gröne, R Tschada, M Hergenhahn and M Hollstein
Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes
doi:10.1038/sj.bjc.6601164
Abstract | Full article | PDF
Mühlradt, P F
J Schmidt, T Welsch, D Jäger, P F Mühlradt, M W Büchler and A Märten
Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial
advance online publication, 2007-07-31 00:00:00.000;
doi:10.1038/sj.bjc.6603903
Abstract | Full article | PDF
Mühr-Wilkenshoff, F
P Grabowski, T Kühnel, F Mühr-Wilkenshoff, B Heine, H Stein, M Höpfner, C T Germer and H Scherübl
Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma
doi:10.1038/sj.bjc.6600696
Abstract | Full article | PDF
Müller, A
C C Schimanski, R Bahre, I Gockel, A Müller, K Frerichs, V Hörner, A Teufel, N Simiantonaki, S Biesterfeld, T Wehler, M Schuler, T Achenbach, T Junginger, P R Galle and M Moehler
Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4
advance online publication, 2006-07-04 00:00:00.000;
doi:10.1038/sj.bjc.6603251
Abstract | Full article | PDF
Müller, B
C S Djuzenova, B Mühl, M Fehn, U Oppitz, B Müller and M Flentje
Radiosensitivity in breast cancer assessed by the Comet and micronucleus assays
advance online publication, 2006-03-14 00:00:00.000;
doi:10.1038/sj.bjc.6603005
Abstract | Full article | PDF
-
Result page:
- 1|
- 2|
- 3|
- 4|
- 5|
- 6|
- 7|
- 8|
- 9|
- 10|
- 11|
- 12|
- 13|
- 14|
- 15|
- 16|
- 17|
- 18|
- 19|
- 20|
- 21|
- 22|
- 23|
- 24|
- 25|
- 26|
- 27|
- 28|
- 29|
- 30|
- 31|
- 32|
- 33|
- 34|
- 35|
- 36|
- 37|
- 38|
- 39|
- 40|
- 41|
- 42|
- 43|
- 44|
- 45|
- 46|
- 47|
- 48|
- 49|
- 50|
- 51|
- 52|
- 53|
- 54|
- 55|
- 56|
- 57|
- 58|
- 59|
- 60|
- 61|
- 62|
- 63|
- 64|
- 65|
- 66|
- 67|
- 68|
- 69|
- 70|
- 71|
- 72|
- 73|
- 74|
- 75|
- 76|
- 77|
- 78|
- 79|
- 80|
- 81|
- 82|
- 83|
- 84|
- 85|
- 86|
- 87|
- 88|
- 89|
- 90|
- 91|
- 92|
- 93|
- 94|
- 95|
- 96|
- 97|
- 98|
- 99|
- 100|
- 101|
- 102|
- 103|
- 104|
- 105|
- 106|
- 107|
- 108|
- 109|
- 110|
- 111|
- 112|
- 113|
- 114|
- 115|
- 116|
- 117|
- 118|
- 119|
- 120|
- 121|
- 122|
- 123|
- 124|
- 125|
- 126|
- 127|
- 128|
- 129|
- 130|
- 131|
- 132|
- 133|
- 134|
- 135|
- 136|
- 137|
- 138|
- 139|
- 140|
- 141|
- 142|
- 143|
- 144|
- 145|
- 146|
- 147|
- 148|
- 149|
- 150|
- 151|
- 152|
- 153|
- 154|
- 155|
- 156|
- 157|
- 158|
- 159|
- 160|
- 161|
- 162|
- 163|
- 164|
- 165|
- 166|
- 167|
- 168|
- 169|
- 170|
- 171|
- 172|
- 173|
- 174|
- 175|
- 176|
- 177|
- 178|
- 179|
- 180|
- 181|
- 182|
- 183|
- 184|
- 185|
- 186|
- 187|
- 188|
- 189|
- 190|
- 191|
- 192|
- 193|
- 194|
- 195|
- 196|
- 197|
- 198|
- 199|
- 200|
- 201|
- 202|
- 203|
- 204|
- 205|
- 206|
- 207|
- 208|
- 209|
- 210|
- 211|
- 212|
- 213|
- 214|
- 215|
- 216|
- 217|
- 218|
- 219|
- 220|
- 221|
- 222|
- 223|
- 224|
- 225|
- 226|
- 227|
- 228|
- 229|
- 230|
- 231|
- 232|
- 233|
- 234|
- 235|
- 236|
- 237|
- 238|
- 239|
- 240|
- 241|
- 242|
- 243|
- 244|
- 245|
- 246|
- 247|
- 248|
- 249|
- 250|
- 251|
- 252|
- 253|
- 254|
- 255|
- 256|
- 257|
- 258|
- 259|
- 260|
- Next
